Non-Small Cell Lung Cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients with histologically confirmed NSCLC 2) Patients with above pathological stage IB and complete resection (including R0 (un)) 3) Patients with no prior treatment of chemotherapy or radiation therapy on NSCLC 4) Patients that are able to treat adjuvant chemotherapy within 8 weeks 5) Patients with more than 60% of Karnofsky Performance Status at the registration 6) Age >=75 years (at the registration) 7) Written informed consent 8) patients with adequate organ function (within 2 weeks before registration): 1.Neutrophils >=3500 /mm3 <12000/mm3 2.Platelet >= 100000/mm3 3.Hemoglobin >= 9.0g/dL 4.AST and ALT < 2 x ULN 5.Total bilirubin < 1.5 mg/dl 6.Serum creatinine <= 1.2 mg/dl 7. PaO2>= 60 Torr or SpO2 >= 92%
Exclusion criteria
Exclusion criteria: 1) Patients with incomplete resection of NSCLC 2) Patients with past history of severe drug allergy 3) Patients with clinically problematic active severe complications 4) Patients with active concomitant malignancy in another organs 5) Any other patients who are regarded as unsuitable for this study by the investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Baseline change of Karnofsky Performance status score | — |
Countries
Japan
Contacts
National Hospital Organization Beppu Medical Center Department of Respiratory Surgery